Pressemitteilung: Kuehne+Nagel finalises agreement with Moderna for Covid-19 vaccine distribution

Aus den Organisationen

• Distribution and central storage at Kuehne+Nagel’s pharma hub • New arrangement leverages Kuehne+Nagel’s global solutions for pharma & healthcare logistics / Moderna, Inc. (NASDAQ:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, and Kuehne+Nagel, a world-leading logistics company, today announced that they have agreed an international supply chain arrangement to provide distribution and storage of the Covid-19 Vaccine Moderna. This announcement follows the granting of conditional marketing authorisation by the European Medicines Agency (EMA) for Covid-19 Vaccine Moderna.

Der vollständige Inhalt dieser Pressemitteilung wird auf unserer Seite nicht angezeigt.
Zum Lesen der Mitteilung klicken Sie bitte auf den folgenden Link:

-> Kuehne+Nagel finalises agreement with Moderna for Covid-19 vaccine distribution

Quelle: Kühne + Nagel (AG & Co.) KG
Zurück